Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer

Status unconfirmed · Phase 1

Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of gemcitabine given as a continuous infusion in treating patients who have advanced metastatic cancer.

Key facts

Study ID

NCT00020644

Run by

Advocate Lutheran General Hospital

Starts

2000-03-01

Last updated by the study team

2013-08-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Lutheran General Cancer Care Center — Park Ridge, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.